![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](jj2088contents.gif)
Acta Cryst. (2011). E67, m624-m625 [ doi:10.1107/S1600536811014462 ]
Abstract: The title compound, bis[
-(E)-2-({2-[4-(dimethylamino)benzoyl]hydrazinylidene}methyl)phenolato]bis[formatozinc], [Zn2(C16H16N3O2)2(CHO2)2], is a dinuclear ZnII complex containing two ZnII cations, two monovalent anions of a Schiff base ligand, 4-dimethylamino-N'-(2-hydroxybenzylidene)benzohydrazide (L), and two formate ions. Each ZnII atom chelates with the hydroxy O atom of salicylaldehyde, the imine N atom, the carbonyl O atom, the formate carboxylate O atom and the hydroxy O atom of the salicylaldehyde moiety in a symmetry-related unit. The five-coordinate ZnII atoms form a dimeric centrosymmetric unit with a central parallelepiped Zn2O2 core and parallel faces derived from the Schiff base ligands. The crystal packing is stabilized by intermolecular N-H
O hydrogen bonds between the amide N atom and the formate carboxylate O atom.
Online 22 April 2011
Copyright © International Union of Crystallography
IUCr Webmaster